Released Mar 16, 2011, during market hours
10-K filed Mar 16, 2011, 75 days after period end · 0001193125-11-068577
Q4 2010 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net income—
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Cash Flowderived$4,249,000—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
no prior Q4 2009 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR